September 2025
1. MULLER F, Atreya R, Volkl S, Aigner M, et al
   CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis.
   N Engl J Med. 2025;393:1239-1241.
   

   >> Share

   
   September 2024
2. SANDS BE, Feagan BG, Peyrin-Biroulet L, Danese S, et al
   Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
   N Engl J Med. 2024;391:1119-1129.
   

   >> Share

   
   August 2024
3. GRIFFIN H, Ceron-Gutierrez L, Gharahdaghi N, Ebrahimi S, et al
   Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
   N Engl J Med. 2024;391:434-441.
   

   >> Share

   
   July 2024
4. ABRAHAM C
   Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation.
   N Engl J Med. 2024;391:275-277.
   

   >> Share

   
   
5. PEYRIN-BIROULET L, Chapman JC, Colombel JF, Caprioli F, et al
   Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
   N Engl J Med. 2024;391:213-223.
   

   >> Share

   
   August 2023
6. 
   Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
   N Engl J Med. 2023;389:772.
   

   >> Share

   
   June 2023
7. D'HAENS G, Dubinsky M, Kobayashi T, Irving PM, et al
   Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
   N Engl J Med. 2023;388:2444-2455.
   

   >> Share

   
   May 2023
8. ABREU MT
   JAK1 Inhibition to Treat Crohn's Disease.
   N Engl J Med. 2023;388:2005-2009.
   

   >> Share

   
   
9. LOFTUS EV JR, Panes J, Lacerda AP, Peyrin-Biroulet L, et al
   Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
   N Engl J Med. 2023;388:1966-1980.
   

   >> Share

   
   March 2023
10. TRAVIS S, Silverberg MS, Danese S, Gionchetti P, et al
    Vedolizumab for the Treatment of Chronic Pouchitis.
    N Engl J Med. 2023;388:1191-1200.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share